From the Journals
Can Peptides Improve Skin Aging?
-
By
-
March 18, 2026
-
3 min
By
March 18, 2026
Phase 3 data showed high skin clearance rates and adverse event rates similar to placebo through week 16 with once-daily icotrokinra.
March 18, 2026
In topline results from Lilly’s ADorable-1 trial, pediatric patients aged 6 months to 18 years had higher rates of skin clearance and itch improvement vs placebo, according to a press release from Eli Lilly and Company.
by Kerri Miller
March 17, 2026
Economic analysis finds large differences in the annual cost of recommended sunscreen use depending on product price and clothing-based sun protection strategies
March 16, 2026